Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT ID: NCT01362829
Last Updated: 2011-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2009-08-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Severe Sepsis Patients in Surgical Intensive Care Units
NCT01919138
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895
The Application of SERS and Metabolomics in Sepsis
NCT02213237
A Prospective Observational Study of Sepsis
NCT05309889
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with severe sepsis
Patients who are admitted to medical ICU with severe sepsis
Determined by intended physician
We perform a prospective observational study. All the treatment for the patients are determined by intended physicians.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Determined by intended physician
We perform a prospective observational study. All the treatment for the patients are determined by intended physicians.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute cardiogenic lung edema
* status asthmatics
* cardiac dysrhythmia as the primary diagnosis
* massive gastrointestinal bleeding
* epileptics
* drug overdose
* requirement of immediate surgery
* hematologic malignancies
* febrile neutropenia
* treatment with immunosuppressive agents before admission
* advanced malignancy and poor pre-admission performance status
* with inevitable short-term mortality or morbidity
* HIV infection
* refusal of consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Far Eastern Memorial Hospital
OTHER
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
National Taiwan University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chong-Jen Yu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Hou-Tai Chang, MD
Role: PRINCIPAL_INVESTIGATOR
Far Eastern Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Far Eastern Memorial Hospital
Taipei, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
098014-3
Identifier Type: OTHER
Identifier Source: secondary_id
200907064R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.